000 | 01188 a2200361 4500 | ||
---|---|---|---|
005 | 20250518081602.0 | ||
264 | 0 | _c20200921 | |
008 | 202009s 0 0 eng d | ||
022 | _a1528-0020 | ||
024 | 7 |
_a10.1182/blood.2019001605 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKlok, Frederikus A | |
245 | 0 | 0 |
_aHow I assess and manage the risk of bleeding in patients treated for venous thromboembolism. _h[electronic resource] |
260 |
_bBlood _c03 2020 |
||
300 |
_a724-734 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Review | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHemorrhage _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPractice Patterns, Physicians' _xstandards |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aVenous Thromboembolism _xdiagnosis |
700 | 1 | _aHuisman, Menno V | |
773 | 0 |
_tBlood _gvol. 135 _gno. 10 _gp. 724-734 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood.2019001605 _zAvailable from publisher's website |
999 |
_c30532278 _d30532278 |